Merus Announces First Patient Treated in Phase 1 Clinical Trial of MCLA-145 for Advanced Solid Tumors

World News: . []

UTRECHT Netherlands May 09 2019 GLOBE NEWSWIRE -- Merus NV LINK  MRUS a clinical-stage immuno-oncology company developing Biclonicsreg innovative full-length human bispecific antibody therapeutics today LINK  that the first pat ient ha...

More news and information about Merus N.V.

Published By:

Globe Newswire: 13:00 GMT Thursday 9th May 2019

Published: .

Search for other references to "merus" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us